Pfizer launches Lyme disease vaccine trial | USA TODAY
August 9, 2022
1,086
16
1
1.57%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
USA Today Episodes Around August 9, 2022
See what was published immediately before and after this episode.
1:00Now PlayingPfizer launches Lyme disease vaccine trial | USA TODAY
YouTube Description
as posted by the channelIf proven safe and effective, the vaccine could help stop tick-borne disease that affect nearly half a million Americans every year.
RELATEDAre you risking Lyme disease? Here’s how to remove ticks
Pfizer and a French partner are launching a large clinical trial of an experimental vaccine that would be the first to prevent Lyme disease, the companies announced Monday.
If proven safe and effective, the vaccine, currently called VLA15, could be an important tool to stop the tick-borne disease that affects nearly half a million Americans a year. Although many people clear the infection with a course of antibiotics, others suffer for years from lingering symptoms.
» Subscribe to USA TODAY
» Watch more on this and other topics from USA TODAY
» USA TODAY delivers current local and national news, sports, entertainment, finance, technology, and more through award-winning journalism, photos, videos and VR.
#Pfizer #Lyme #France
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.